Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Shenzhen Hepalink Pharmaceutical Group Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 11 Jul 2023 | Cytovance Biologics Forms Partnership with Phenotypeca | Partnership | - |
Cytovance Biologics Inc
Phenotypeca Ltd
|
| 27 Mar 2023 | Orient EuroPharma Enters into Licensing Agreement with Shenzhen Angrui Biomedical (Onrui Biomedical) | Licensing Agreement |
Orient Europharma Co Ltd
|
Shenzhen Angrui Biomedical Technology Co., Ltd.
|
| 05 May 2021 | Resverlogix Raises USD6 Million in Private Placement of 10% Debentures due 2022 | Debt Offering |
Shenzhen Hepalink Pharmaceutical Group Co Ltd
|
Resverlogix Corp
|
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer